178 related articles for article (PubMed ID: 28189595)
1. Class 3 semaphorins are transcriptionally regulated by 1,25(OH)
Ryynänen J; Kriebitzsch C; Meyer MB; Janssens I; Pike JW; Verlinden L; Verstuyf A
J Steroid Biochem Mol Biol; 2017 Oct; 173():185-193. PubMed ID: 28189595
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.
Sutton AL; Zhang X; Dowd DR; Kharode YP; Komm BS; Macdonald PN
Mol Endocrinol; 2008 Jun; 22(6):1370-81. PubMed ID: 18356290
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.
Hughes A; Kleine-Albers J; Helfrich MH; Ralston SH; Rogers MJ
Calcif Tissue Int; 2012 Feb; 90(2):151-62. PubMed ID: 22227882
[TBL] [Abstract][Full Text] [Related]
5. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
Sutton AL; Zhang X; Ellison TI; Macdonald PN
Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
[TBL] [Abstract][Full Text] [Related]
6. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
7. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
8. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation.
Meyer MB; Benkusky NA; Lee CH; Pike JW
J Biol Chem; 2014 Jul; 289(28):19539-54. PubMed ID: 24891508
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 and the aging-related forkhead box O and sestrin proteins in osteoblasts.
Eelen G; Verlinden L; Meyer MB; Gijsbers R; Pike JW; Bouillon R; Verstuyf A
J Steroid Biochem Mol Biol; 2013 Jul; 136():112-9. PubMed ID: 22989484
[TBL] [Abstract][Full Text] [Related]
10. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
11. Mannose receptor C type 2 mediates 1,25(OH)
Dong Y; Yang L; Luo W; Zhu T; Yan W; Kong J; Yuan Z; Zhao Q
Mol Cell Endocrinol; 2019 Mar; 483():74-86. PubMed ID: 30641101
[TBL] [Abstract][Full Text] [Related]
12. Mechanical loading and the synthesis of 1,25(OH)2D in primary human osteoblasts.
van der Meijden K; Bakker AD; van Essen HW; Heijboer AC; Schulten EA; Lips P; Bravenboer N
J Steroid Biochem Mol Biol; 2016 Feb; 156():32-9. PubMed ID: 26625962
[TBL] [Abstract][Full Text] [Related]
13. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
Matsumoto T; Igarashi C; Takeuchi Y; Harada S; Kikuchi T; Yamato H; Ogata E
Bone; 1991; 12(1):27-32. PubMed ID: 2054233
[TBL] [Abstract][Full Text] [Related]
14. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways.
Farach-Carson MC; Ridall AL
Am J Kidney Dis; 1998 Apr; 31(4):729-42. PubMed ID: 9531195
[TBL] [Abstract][Full Text] [Related]
15. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
16. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 upregulates natriuretic peptide receptor-C expression in mouse osteoblasts.
Yanaka N; Akatsuka H; Kawai E; Omori K
Am J Physiol; 1998 Dec; 275(6):E965-73. PubMed ID: 9843738
[TBL] [Abstract][Full Text] [Related]
18. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
19. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
Tanaka M; Muramatsu M; Higuchi S; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
[TBL] [Abstract][Full Text] [Related]
20. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL
Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
